Long-Term Outcomes of Liver Transplantation in Type 1 Gaucher Disease

被引:20
|
作者
Ayto, R. M. [1 ]
Hughes, D. A. [1 ]
Jeevaratnam, P. [1 ]
Rolles, K. [2 ,3 ]
Burroughs, A. K. [2 ,3 ]
Mistry, P. K. [4 ]
Mehta, A. B. [1 ]
Pastores, G. M. [5 ,6 ]
机构
[1] Univ London Royal Free Hosp, Dept Haematol, Lysosomal Storage Disorders Unit, London NW3 2QG, England
[2] Univ London Royal Free Hosp, Royal Free Sheila Sherlock Liver Ctr, London NW3 2QG, England
[3] Univ London Royal Free Hosp, Univ Dept Surg, London NW3 2QG, England
[4] Yale Univ, Sch Med, Dept Pediat Gastroenterol & Hepatol, New Haven, CT USA
[5] NYU, Dept Neurol, Sch Med, New York, NY 10016 USA
[6] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA
关键词
Gaucher; liver; transplantation; ENZYME REPLACEMENT THERAPY; HEPATIC-FIBROSIS; ABNORMALITIES; ELEVATION; REGISTRY; CHILDREN;
D O I
10.1111/j.1600-6143.2010.03168.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Gaucher disease (GD) is the most prevalent lysosomal storage disorder. Enzyme replacement therapy (ERT) has demonstrable efficacy in reversing clinical and pathological manifestations of GD. We report four patients with GD and severe hepatic impairment who were successfully treated by orthotopic liver transplantation. Liver failure resulted from GD in two patients and due to a comorbidity in two others (HCV and autoimmune chronic active hepatitis). Following successful liver transplantation, patients received long-term ERT. Liver transplantation is a life-saving treatment for end-stage liver disease in patients with Gaucher disease. All four patients have had excellent outcomes from liver transplantation for up to 10 years postprocedure with no evidence of Gaucher-related pathology in the graft.
引用
收藏
页码:1934 / 1939
页数:6
相关论文
共 50 条
  • [21] Long-Term Outcomes of Emergency Liver Transplantation for Acute Liver Failure
    Chan, Gabriel
    Taqi, Ali
    Marotta, Paul
    Levstik, Mark
    McAlister, Vivian
    Wall, William
    Quan, Douglas
    LIVER TRANSPLANTATION, 2009, 15 (12) : 1696 - 1702
  • [22] Pulmonary vascular disease in Gaucher disease: Genotype/Phenotype characteristics and long-term outcomes
    Lo, Sarah
    Liu, Jun
    Pastores, Gregory
    Knowles, James
    Boxer, Michael
    Korson, Mark
    Alec, Kirk
    Mistry, Pramod
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (02) : S25 - S26
  • [23] Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry
    El-Beshlawy, Amal
    Tylki-Szymanska, Anna
    Vellodi, Ashok
    Belmatoug, Nadia
    Grabowski, Gregory A.
    Kolodny, Edwin H.
    Batista, Julie L.
    Cox, Gerald F.
    Mistry, Pramod K.
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : 47 - 56
  • [24] Long-Term Outcomes and Predictors of Survival after Liver Transplantation for Wilson Disease (WD).
    Jalal, P.
    May, S.
    Rana, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 576 - 577
  • [25] Long-term Outcomes of Kidney Transplantation in Fabry Disease
    Ersozlu, Sara
    Desnick, Robert J.
    Uyen Huynh-Do
    Canaan-Kuehl, Sima
    Barbey, Frederic
    Genitsch, Vera
    Mueller, Thomas F.
    Cheetham, Marcus
    Flammer, Andreas J.
    Schaub, Stefan
    Nowak, Albina
    TRANSPLANTATION, 2018, 102 (11) : 1924 - 1933
  • [26] Eight-year clinical outcomes of long-term enzyme replacement therapy in 884 children with type 1 Gaucher disease
    Andersson, H.
    Kaplan, P.
    Kacena, K.
    Yee, J.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 103 - 103
  • [27] Eight-Year Clinical Outcomes of Long-Term Enzyme Replacement Therapy for 884 Children With Gaucher Disease Type 1
    Andersson, Hans
    Kaplan, Paige
    Kacena, Katherine
    Yee, John
    PEDIATRICS, 2008, 122 (06) : 1182 - 1190
  • [28] Long-term outcomes of kidney transplantation in Fabry disease
    Nowak, Albina
    Desnick, Robert J.
    Huynh-Do, Uyen
    Canaan-Kuehl, Sima
    Barbey, Frederic
    Genitsch, Vera
    Mueller, Thomas
    Cheetham, Marcus
    Flammera, Andreas J.
    Schaub, Stefan
    Ersozlu, Sara
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S108 - S108
  • [29] ADULT PATIENTS WITH TYPE I GAUCHER DISEASE (GD 1) ON LONG-TERM MIGLUSTAT TREATMENT
    Hollak, C.
    Heitner, R.
    Hrebicek, M.
    Elstein, D.
    Zimran, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 171 - 171
  • [30] Long-term Outcomes of Living-donor Liver Transplantation for Progressive Familial Intrahepatic Cholestasis Type 1
    Okamoto, Tatsuya
    Sonoda, Mari
    Ogawa, Eri
    Ito, Shogo
    Togawa, Takao
    Hayashi, Hisamitsu
    Okajima, Hideaki
    Uemoto, Shiji
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2021, 72 (03): : 425 - 429